Download PDF
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Fibromyalgia with elevated rheumatoid factor is associated with poor therapeutic response but not with progression to rheumatoid arthritis. Prospective cohort study
Freddy Liñán Ponce; Juan Leiva Goicochea; David Sevilla Rodríguez; Elmer Hidalgo Bravo; Ginna Obregón Atanacio; Inés Loyola Macalapú; Paola Jáuregui Rojas; Jackeline Yampufe Canani;
Reumatol Clin. 2024;20:459-62
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries
J.M. Reyes; M.V. Gutierrez; H. Madariaga; W. Otero; R. Guzman; J. Izquierdo; M. Abello; P. Velez; D. Castillo; D. Ponce de Leon; T. Lukic; L. Amador;
Reumatol Clin. 2023;19:319-27
Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile
Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;
Reumatol Clin. 2025;21: